AS
Aurora Spine Corporation
ASAPF · OTC
$0.10 +0.00% (+$0.00)
1M -41.81%
Market Cap $7.75M
P/E Ratio -
Div. Yield -
ROE 33.93%
Bulios Fair Price
$0.06
39.6% downside
Current Price
$0.099
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ASAPF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
39 /100
Fair P/B 2.75x
EV/EBITDA 40.43x
P/FCF 30.97x
Growth
46 /100
Stable Book val. growth 4.11%
Rev. growth 7.90%
FCF growth N/A
Profitability
12 /100
Weak Op. margin 4.97%
Gross margin 22.64%
FCF margin 1.44%
Quality
15 /100
Poor ROA 13.40%
ROIC 13.74%
Asset turnover 1.95x
Debt
34 /100
Moderate Int. coverage -2.91x
Debt/Equity 0.77x
Net debt/EBITDA 7.64x
Stability
61 /100
Moderate EPS volatility 25.02%
Beta -0.56x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ASAPF
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Trent J. Northcutt
Employees
18
Headquarters
Toronto
Upcoming events
16 NOV
Earnings
Upcoming earnings report